Covaxin, India’s first indigenous vaccine for Covid-19, is “safe, immunogenic with no serious side effects”, says leading medical journal The Lancet in its interim efficacy analysis, says an article published in Economic Times.
Vaccine’s Phase 2 resultsThe Lancet – Infectious Diseases Journal, published phase 2 results of the vaccine developed by Hyderabad-based Bharat Biotech.
However, the report made it clear that efficacy cannot be determined by phase 2 trials and this required further...
https://mfame.guru/covaxin-is-safe-with-no-serious-side-effects-says-leading-medical-journal/